A Siderowf

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Parkinson's disease: clinical features, epidemiology and genetics
    A Siderowf
    Parkinson s Disease and Movement Disorders Center, University of Pennsylvania, Philadelphia, Pennsylvania 19107, USA
    Neurol Clin 19:565-78, vi. 2001
  2. pmc Premotor Parkinson's disease: concepts and definitions
    Andrew Siderowf
    Parkinson s Disease and Mov Disord Center, Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Mov Disord 27:608-16. 2012
  3. pmc CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease
    A Siderowf
    Department of Neurology, 330 South 9th Street, Second Floor, Philadelphia, PA 19107, USA
    Neurology 75:1055-61. 2010
  4. ncbi [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease
    A Siderowf
    Parkinson Disease and Movement Disorders Center, Department of Neurology, University of Pennsylvania, Philadelphia, USA
    Neurology 64:1716-20. 2005
  5. pmc Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study
    R N Alcalay
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Neurology 78:1434-40. 2012
  6. pmc The relation between depression and parkin genotype: the CORE-PD study
    A Srivastava
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Parkinsonism Relat Disord 17:740-4. 2011
  7. pmc Novel CSF biomarkers for frontotemporal lobar degenerations
    W T Hu
    Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia 19104 4283, USA
    Neurology 75:2079-86. 2010
  8. ncbi Interest in predictive testing for Parkinson's disease: impact of neuroprotective therapy
    N Dahodwala
    Department of Neurology, Pennsylvania Hospital, University of Pennsylvania, USA
    Parkinsonism Relat Disord 13:495-9. 2007
  9. pmc Multiple pathologies in a patient with a progressive neurodegenerative syndrome
    T W Liang
    Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Neurol Neurosurg Psychiatry 76:252-5. 2005
  10. pmc Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study
    R N Alcalay
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Neurology 76:319-26. 2011

Collaborators

Detail Information

Publications15

  1. ncbi Parkinson's disease: clinical features, epidemiology and genetics
    A Siderowf
    Parkinson s Disease and Movement Disorders Center, University of Pennsylvania, Philadelphia, Pennsylvania 19107, USA
    Neurol Clin 19:565-78, vi. 2001
    ..This article reviews the clinical features, epidemiology and genetics of PD, with emphasis on insights from recent genetic and epidemiological studies...
  2. pmc Premotor Parkinson's disease: concepts and definitions
    Andrew Siderowf
    Parkinson s Disease and Mov Disord Center, Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Mov Disord 27:608-16. 2012
    ....
  3. pmc CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease
    A Siderowf
    Department of Neurology, 330 South 9th Street, Second Floor, Philadelphia, PA 19107, USA
    Neurology 75:1055-61. 2010
    ..Cognitive decline associated with Parkinson disease (PD) is common and highly disabling. Biomarkers that help identify patients at risk for cognitive decline would be useful additions to the clinical management of the disease...
  4. ncbi [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease
    A Siderowf
    Parkinson Disease and Movement Disorders Center, Department of Neurology, University of Pennsylvania, Philadelphia, USA
    Neurology 64:1716-20. 2005
    ..In vivo imaging of the dopamine transporter with [99mTc]TRODAT-1 (TRODAT) and olfactory testing have both been proposed as potential biomarkers in Parkinson disease (PD)...
  5. pmc Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study
    R N Alcalay
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Neurology 78:1434-40. 2012
    ..To assess the cognitive phenotype of glucocerebrosidase (GBA) mutation carriers with early-onset Parkinson disease (PD)...
  6. pmc The relation between depression and parkin genotype: the CORE-PD study
    A Srivastava
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Parkinsonism Relat Disord 17:740-4. 2011
    ..Genetic factors for depression are similarly not well characterized. We investigate the role of parkin mutations in depression among those with EOPD and their relatives...
  7. pmc Novel CSF biomarkers for frontotemporal lobar degenerations
    W T Hu
    Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia 19104 4283, USA
    Neurology 75:2079-86. 2010
    ..To identify antemortem CSF diagnostic biomarkers that can potentially distinguish between the 2 main causes of frontotemporal lobar degeneration (FTLD), i.e., FTLD with TDP-43 pathology (FTLD-TDP) and FTLD with tau pathology (FTLD-tau)...
  8. ncbi Interest in predictive testing for Parkinson's disease: impact of neuroprotective therapy
    N Dahodwala
    Department of Neurology, Pennsylvania Hospital, University of Pennsylvania, USA
    Parkinsonism Relat Disord 13:495-9. 2007
    ..001). Interest in predictive testing for PD is moderate in the absence of effective therapy, and goes up significantly when both clinical trial participation and neuroprotective therapy are offered...
  9. pmc Multiple pathologies in a patient with a progressive neurodegenerative syndrome
    T W Liang
    Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Neurol Neurosurg Psychiatry 76:252-5. 2005
    ..This case raises the possibility that three distinct neuropathological diagnoses share a common aetiology...
  10. pmc Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study
    R N Alcalay
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Neurology 76:319-26. 2011
    ..Whether olfaction differs between Parkin mutation heterozygotes and carriers of 2 Parkin mutations (compound heterozygotes) is unknown...
  11. ncbi Postural change of forced vital capacity predicts some respiratory symptoms in ALS
    J Varrato
    Department of Neurology, University of Pennsylvania, Philadelphia, USA
    Neurology 57:357-9. 2001
    ..The supine FVC is significantly lower and the erect--supine FVC difference is significantly greater in patients with complaints of dyspnea, orthopnea, and daytime fatigue...
  12. ncbi Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson's disease
    K L Chou
    Parkinson s Disease and Movement Disorders Center, University of Pennsylvania School of Medicine, Pennsylvania Hospital, 330 South Ninth Street, Philadelphia, PA 19107, USA
    Parkinsonism Relat Disord 10:375-9. 2004
    ..79, specificity 0.92). These findings show that TRODAT imaging can accurately differentiate early PD patients from controls and has the potential to improve the diagnosis of patients with early signs of PD...
  13. ncbi Venous thrombosis in an ALS population over four years
    L B Elman
    Penn Neurological Institute, 330 South 9th Street, University of Pennsylvania, Philadelphia, PA 19107, USA
    Amyotroph Lateral Scler Other Motor Neuron Disord 6:246-9. 2005
    ..Immobility was significantly associated with increased risk of venous thrombosis (RR = 4.96; 95% CI 1.39-17.78)...
  14. ncbi Emergence of complex, involuntary movements after gamma knife radiosurgery for essential tremor
    A Siderowf
    Department of Neurology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Mov Disord 16:965-7. 2001
    ..This case illustrates the need for long-term follow-up to fully evaluate the potential for complications following radiosurgery...
  15. ncbi Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
    E R Dorsey
    Department of Neurology, University of Rochester Medical Center, 1351 Mt Hope Blvd, Suite 223, Rochester, NY 14620, USA
    Neurology 68:384-6. 2007
    ..The number of individuals with PD over age 50 in these countries was between 4.1 and 4.6 million in 2005 and will double to between 8.7 and 9.3 million by 2030...